Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials-Reference-Cited by-同舟云学术

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

Published:2021-02 Issue: Volume:144 Page:101-112
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sinicrope Frank A.,Chakrabarti Sakti,Laurent-Puig Pierre,Huebner Luke,Smyrk Thomas C.,Tabernero Josep,Mini Enrico,Goldberg Richard M.,Zaanan Aziz,Folprecht Gunnar^ORCID,Van Laethem Jean Luc,Le Malicot Karine^ORCID,Shi Qian,Alberts Steven R.,Taieb Julien

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial;Alberts;J Am Med Assoc,2012

2. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study;Andre;J Clin Oncol,2015

3. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial;Taieb;Lancet Oncol,2014

4. Duration of adjuvant chemotherapy for stage III colon cancer;Grothey;N Engl J Med,2018

5. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Argiles;Ann Oncol,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts;European Journal of Cancer;2024-07

2. Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer;Targeted Oncology;2024-04-30

3. Sidedness is not a prognostic factor in an unselected cohort of patients with colon cancer but prognosis for caecal carcinoma is worse – A multivariate analysis of a large single institution database;International Journal of Colorectal Disease;2024-02-13

4. Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis;Cancers;2023-12-27

5. The effect of adjuvant chemotherapy on survival in node negative colorectal cancer with or without perineural invasion: a systematic review and meta-analysis;Frontiers in Surgery;2023-11-16